摘要
目的研究清络通痹方(Qingluo-Tongbi Grannual,QLT)对类风湿关节炎(rheumatoid arthritis,RA)患者外周血T淋巴细胞表达RANKL(receptor activator of nuclear factor-κB ligand,破骨细胞分化因子)的影响。方法临床纳入15例RA患者,肘静脉抽血10ml,每个血样分为5组,包括正常对照组,阳性对照组,和QLT小、中、大三个剂量组。血样加药培养72小时后,加入FITC标记的CD3抗体和PE标记的RANKL抗体,采用流式细胞术检测RANKL的表达率。结果采用中剂量和大剂量QLT动物含药血清培养的T淋巴细胞RANKL表达率受到了显著的抑制,与正常对照组比较具有统计学差异(P<0.01)。结论 QLT可以有效下调RA患者外周血T淋巴细胞RANKL的表达。
Objective To study the effect of medicated serum containing Qingluo - tongbi Granule (QLT) on RANKL ( receptor activator of nuclear factor - KB ligand) expression of T lymphocytes extracted from peripheral blood of rheumatoid arthritis (RA) patients. Methods Blood samples extracted from veins of 15 RA cases were divided into 5 groups, including normal control, positive control, small - dose QLT, medium - dose as well as large - dose. Samples were cultured, processed under general program and tested with flow cytometer after antibodies of FITC labeled anti -human CD3 and PE labeled anti -human RANKL were added in. Results Compared with normal control group, RANKL expression of T lymphocytes treated with serum containing medium or large dose QLT was inhibited obviously in vitro ( P 〈 0.01 ), and QLT demonstrate effect to suppress RANKL expression. Conclusion QLT is able to suppress RANKL over - expression of T lymphocytes of RA patients.
出处
《时珍国医国药》
CAS
CSCD
北大核心
2012年第2期465-467,共3页
Lishizhen Medicine and Materia Medica Research
基金
this study is supported by Scientific Research Launching Fund of China Education Ministry for Returnees(No.2006331)
Jiangsu Provincial Innovation Foundation For Postgraduate(No.2010)~~